Matches in SemOpenAlex for { <https://semopenalex.org/work/W3108587488> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W3108587488 endingPage "798" @default.
- W3108587488 startingPage "793" @default.
- W3108587488 abstract "Material and methods. A total of 125 patients(pts) with HCC (stage BCLC-B) underwent TACE from 2009 to 2016. If pts had been found inoperable, radiological intervention was used as monotherapy or in combination with systemic therapy at different stages of the disease. Results. Median overall survival (OS) for pts subjected to at least one TACE session was 20.5 months (95 per cent confidence interval 16.4-24.59). Such factors as ECOG status (р=0,012, RR= 1,65), protein synthesis (albumin >37 г/л; р=0,005, RR = 0,47) and detoxication (total bilirubin ≤ 14 мкмоль/л; р=0,037, RR = 1,64) hepatic functions, functional hepatic ability according to Child-Pugh classification (А vs. B; p=0,016, RR = 2,5) ALBI categories (A1 vs. A2 vs. A3; р=0,007, RR = 1,66) as well as HCC invasion: tumour size (р=0,001, RR=2,1), level AFP ≥ 5 IU/ml (р=0,003, RR 2,25), bilobar involvement (р=0,024; RR=1,64) independently influence OS. Pronounced TACE effect (р<0,001, RR 1,93) and Time before Progression duration were found to influence significantly the fatality rate. Multifactorial analysis for OS confirmed increased mortality (RR=1,92) if total bilirubin was ≥14 umol/L (р=0,018); Impaired hepatic functions according to ALBI (р=0,007) and Child-Pugh classification (р=0,002) are associated with significant OS reduction (RR 1.73 и 3,41respectively). HCC invasion (BCLC; р=0,03) AFP level ≥5 IU/ml (р=0,008, RR=2,26) and the biggest tumour node size >10 см (р=0,01, RR 1,95) independently increase mortality rate. Effective TACE (р<0,001) is associated with significant OS increase and mortality decrease. Conclusion. TACE is most effective if HCC pts have satisfactory condition and preserved liver function (Child Pugh A or ALBIA1) and limited intrahepatic invasion (BCLCA/B), with tumour size being... cm and normal AFP level. Under conditions of intrahepatic progression subsequent local therapy was found to be significantly associated with OS increase." @default.
- W3108587488 created "2020-12-07" @default.
- W3108587488 creator A5027237323 @default.
- W3108587488 creator A5028258803 @default.
- W3108587488 creator A5040211114 @default.
- W3108587488 creator A5047547717 @default.
- W3108587488 creator A5057014825 @default.
- W3108587488 creator A5073763820 @default.
- W3108587488 creator A5085103480 @default.
- W3108587488 creator A5085517844 @default.
- W3108587488 creator A5085572542 @default.
- W3108587488 creator A5091644420 @default.
- W3108587488 date "2018-06-01" @default.
- W3108587488 modified "2023-09-27" @default.
- W3108587488 title "TRANSARTERIAL CHEMOEMBOLIZATION(TACE) EFFICACY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA(HCC): CAN SIGNIFICANT PROGNOSTIC FACTORS BE REVEALED?" @default.
- W3108587488 doi "https://doi.org/10.37469/0507-3758-2018-64-6-793-798" @default.
- W3108587488 hasPublicationYear "2018" @default.
- W3108587488 type Work @default.
- W3108587488 sameAs 3108587488 @default.
- W3108587488 citedByCount "0" @default.
- W3108587488 crossrefType "journal-article" @default.
- W3108587488 hasAuthorship W3108587488A5027237323 @default.
- W3108587488 hasAuthorship W3108587488A5028258803 @default.
- W3108587488 hasAuthorship W3108587488A5040211114 @default.
- W3108587488 hasAuthorship W3108587488A5047547717 @default.
- W3108587488 hasAuthorship W3108587488A5057014825 @default.
- W3108587488 hasAuthorship W3108587488A5073763820 @default.
- W3108587488 hasAuthorship W3108587488A5085103480 @default.
- W3108587488 hasAuthorship W3108587488A5085517844 @default.
- W3108587488 hasAuthorship W3108587488A5085572542 @default.
- W3108587488 hasAuthorship W3108587488A5091644420 @default.
- W3108587488 hasBestOaLocation W31085874881 @default.
- W3108587488 hasConcept C126322002 @default.
- W3108587488 hasConcept C146357865 @default.
- W3108587488 hasConcept C151730666 @default.
- W3108587488 hasConcept C2777513400 @default.
- W3108587488 hasConcept C2778019345 @default.
- W3108587488 hasConcept C44249647 @default.
- W3108587488 hasConcept C71924100 @default.
- W3108587488 hasConcept C82789193 @default.
- W3108587488 hasConcept C86803240 @default.
- W3108587488 hasConcept C90924648 @default.
- W3108587488 hasConceptScore W3108587488C126322002 @default.
- W3108587488 hasConceptScore W3108587488C146357865 @default.
- W3108587488 hasConceptScore W3108587488C151730666 @default.
- W3108587488 hasConceptScore W3108587488C2777513400 @default.
- W3108587488 hasConceptScore W3108587488C2778019345 @default.
- W3108587488 hasConceptScore W3108587488C44249647 @default.
- W3108587488 hasConceptScore W3108587488C71924100 @default.
- W3108587488 hasConceptScore W3108587488C82789193 @default.
- W3108587488 hasConceptScore W3108587488C86803240 @default.
- W3108587488 hasConceptScore W3108587488C90924648 @default.
- W3108587488 hasIssue "6" @default.
- W3108587488 hasLocation W31085874881 @default.
- W3108587488 hasOpenAccess W3108587488 @default.
- W3108587488 hasPrimaryLocation W31085874881 @default.
- W3108587488 hasRelatedWork W1974713739 @default.
- W3108587488 hasRelatedWork W2111144600 @default.
- W3108587488 hasRelatedWork W2212763461 @default.
- W3108587488 hasRelatedWork W2356105190 @default.
- W3108587488 hasRelatedWork W2939697310 @default.
- W3108587488 hasRelatedWork W2943140820 @default.
- W3108587488 hasRelatedWork W3029220886 @default.
- W3108587488 hasRelatedWork W3174235554 @default.
- W3108587488 hasRelatedWork W4311483706 @default.
- W3108587488 hasRelatedWork W4384941320 @default.
- W3108587488 hasVolume "64" @default.
- W3108587488 isParatext "false" @default.
- W3108587488 isRetracted "false" @default.
- W3108587488 magId "3108587488" @default.
- W3108587488 workType "article" @default.